COVID-19 Solidarity Response Fund launched to support global preparedness


  • Heather Mason
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

According to the latest media release from the WHO (18 March), over 200,000 cases of COVID-19 have been reported, with over 8,000 deaths. Over 80 per cent of cases are within the Western Pacific and European regions.

The WHO continues to recommend isolating, testing and treating EVERY suspected case and tracing every contact, as the backbone response in each country. Confirmed mild cases should be isolated in health centres, preventing clinical progression and community transmission.

The first vaccine trial is underway, just 60 days after the genetic sequence was shared. The WHO and partners have organised a large, international study, the ‘Solidarity trial’. To date, 10 countries have confirmed their participation and it’s hoped that more will join.

The COVID-19 Solidarity Response Fund has raised over US$43 million in the few days since its launch. The fund was created to help countries manage COVID, particularly those where the needs are greatest. It will provide essential supplies, such as personal protective equipment, and enable countries to boost laboratory capacity, track, and ensure health workers and communities have access to the latest science-based information, and accelerate efforts to fast-track the discovery and development of vaccines, diagnostics and treatments.

You can donate here.